L3VLUP
ProSign in

WST in the 13F filings

West Pharmaceutical SVSC Inc · CUSIP 955306105

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
latest of these filings; the earliest 12 Nov 2024
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 11 listed it in both
Shares listed
9,766,985
combined, among listed positions
Reported value
$2.9bn
combined, at the quarter end

Among the 94 comparable managers: 9 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing WST in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Artisan Partners LP3,066,527$920m1.37%Added+574,63512 Nov 2024 (the filing on sec.gov)
AllianceBernstein LP2,603,546$781m0.26%Added+374,33114 Nov 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc1,261,478$379munder 0.1%Trimmed-432,34914 Nov 2024 (the filing on sec.gov)
Durable Capital Partners LP1,085,919$326m2.38%Added+45,39514 Nov 2024 (the filing on sec.gov)
MFS Investment Management577,417$173m0.05%Trimmed-59,15612 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC376,403$113m0.09%Trimmed-44,20114 Nov 2024 (the filing on sec.gov)
Capital Research Global Investors160,193$48munder 0.1%Newnew13 Nov 2024 (the filing on sec.gov)
Voloridge Investment Management LLC146,402$44m0.16%Added+88,71214 Nov 2024 (the filing on sec.gov)
Two Sigma Investments LP144,720$43m0.10%Added+62,33714 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP128,259$38munder 0.1%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Holocene Advisors LP109,440$33m0.13%Trimmed-76,69314 Nov 2024 (the filing on sec.gov)
Moore Capital Management LP65,000$20m0.36%Trimmed-15,00014 Nov 2024 (the filing on sec.gov)
Two Sigma Advisers LP39,100$12munder 0.1%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Winton Group Ltd2,581$775k0.05%Added+29212 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
14 in Q3 2024 to 12 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
WST by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20133$230mn.a.n.a.
Q3 20134$290mn.a.n.a.
Q4 20135$370mn.a.n.a.
Q1 20144$348mn.a.n.a.
Q2 20144$344mn.a.n.a.
Q3 20143$349mn.a.n.a.
Q4 20143$403mn.a.n.a.
Q1 20154$757mn.a.n.a.
Q2 20154$795mn.a.n.a.
Q3 20154$798mn.a.n.a.
Q4 20154$896mn.a.n.a.
Q1 20164$1.0bnn.a.n.a.
Q2 20166$1.0bnn.a.n.a.
Q3 20167$1.1bnn.a.n.a.
Q4 20167$1.4bnn.a.n.a.
Q1 20178$1.3bnn.a.n.a.
Q2 201712$1.4bnn.a.n.a.
Q3 20175$1.4bnn.a.n.a.
Q4 20178$1.6bnn.a.n.a.
Q1 20188$1.5bnn.a.n.a.
Q2 20188$1.7bnn.a.n.a.
Q3 201811$2.1bnn.a.n.a.
Q4 201810$1.7bnn.a.n.a.
Q1 201914$2.0bnn.a.n.a.
Q2 201912$2.2bnn.a.n.a.
Q3 201920$2.6bnn.a.n.a.
Q4 201912$2.4bnn.a.n.a.
Q1 202019$2.3bnn.a.n.a.
Q2 202016$3.2bnn.a.n.a.
Q3 202020$3.8bnn.a.n.a.
Q4 202018$3.9bnn.a.n.a.
Q1 202115$3.6bnn.a.n.a.
Q2 202116$4.9bnn.a.n.a.
Q3 202121$5.9bnn.a.n.a.
Q4 202118$6.8bnn.a.n.a.
Q1 202220$6.3bnn.a.n.a.
Q2 202219$4.4bnn.a.n.a.
Q3 202223$2.9bnn.a.n.a.
Q4 202220$2.2bnn.a.n.a.
Q1 202319$3.9bnn.a.n.a.
Q2 202319$4.1bnn.a.n.a.
Q3 202320$4.3bnn.a.n.a.
Q4 202316$3.5bn710
Q1 202417$4.1bn127
Q2 202414$3.2bn97
Q3 202414$2.9bn95
Q4 202417$3.0bn118
Q1 202512$1.4bn94
Q2 202513$1.3bn123
Q3 202513$2.1bn122
Q4 202516$1.6bn2514
Q1 202612$1.3bn2120
Q2 202612$3.1bn1520

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

WST and LLY →WST and JNJ →WST and VRTX →Choose a stock to compare with WST →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own WST, latest filings →Back to the 13F Explorer →